Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC reaffirmed their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research note published on Tuesday, Benzinga reports. They currently have a $50.00 price target on the stock. Several other research analysts also recently weighed in on HRMY. Bank of America restated an underperform rating and issued […]
/PRNewswire/ Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced an exclusive licensing agreement with Bioprojet to develop, manufacture and.
Harmony Biosciences Announces Exclusive Agreement To Develop And Commercialize Tpm-1116, A Highly Potent And Selective Oral Orexin-2 Receptor Agonist finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) shares saw strong trading volume on Monday . 362,007 shares traded hands during trading, a decline of 1% from the previous session’s volume of 363,865 shares.The stock last traded at $29.98 and had previously closed at $30.65. Wall Street Analysts Forecast Growth A number of equities […]